Cite Filings / KYMR / 0001628280-26-046098
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
144

Sale of Securities

Kymera Therapeutics, Inc. · Filed 2026-06-29 · Acc 0001628280-26-046098

Documents 1

  • 144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

  • 2026-07-01 144 Sale of Securities
  • 2026-06-30 144 Sale of Securities
  • 2026-06-30 4 Director sold 31,283 shares at an average $109.48 ($3,424,800)
  • 2026-06-30 4 Director sold 513,245 shares at an average $110.01 ($56,460,136)
  • 2026-06-29 144 Sale of Securities
  • 2026-06-29 144 Sale of Securities
  • 2026-06-26 SCHEDULE 13D/A Beneficial Ownership Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…